Treace Medical Concepts, Inc. Earnings Per Share, Basic and Diluted
Treace Medical Concepts, Inc. (TMCI) reported Earnings Per Share, Basic and Diluted of -$0.16 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-06.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-06
- Treace Medical Concepts, Inc. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.16.
- Treace Medical Concepts, Inc. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.12, a 289.45% decline year-over-year.
- Treace Medical Concepts, Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.12.
- Treace Medical Concepts, Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.10.
- Treace Medical Concepts, Inc. earnings per share, basic and diluted for fiscal 2021 was -$0.43.
- Treace Medical Concepts, Inc. earnings per share, basic and diluted for fiscal 2020 was -$0.12.
- Treace Medical Concepts, Inc. earnings per share, basic and diluted for fiscal 2019 was -$0.13.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$0.16 10-Q · filed 2022-05-06 | -$0.29 derived: net income ÷ weighted average shares · filed 2024-02-27 | -$0.41 derived: net income ÷ weighted average shares · filed 2024-02-27 | -$0.52 derived: net income ÷ weighted average shares · filed 2024-02-27 |
| 2021-12-31 | -$0.12 derived: net income ÷ weighted average shares · filed 2024-02-27 | -$0.24 derived: net income ÷ weighted average shares · filed 2024-02-27 | -$0.35 derived: net income ÷ weighted average shares · filed 2024-02-27 | -$0.43 10-K · filed 2022-03-04 |
| 2021-09-30 | -$0.12 10-Q · filed 2021-11-04 | -$0.23 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$0.30 10-Q · filed 2021-11-04 | -$0.27 derived: net income ÷ weighted average shares · filed 2023-03-08 |
| 2021-06-30 | -$0.10 10-Q · filed 2021-08-05 | -$0.18 10-Q · filed 2021-08-05 | -$0.13 derived: net income ÷ weighted average shares · filed 2023-03-08 | -$0.20 derived: net income ÷ weighted average shares · filed 2023-03-08 |
| 2021-03-31 | -$0.07 10-Q · filed 2022-05-06 | -$0.00 derived: net income ÷ weighted average shares · filed 2023-03-08 | -$0.08 derived: net income ÷ weighted average shares · filed 2023-03-08 | -$0.14 derived: net income ÷ weighted average shares · filed 2023-03-08 |
| 2020-12-31 | $0.06 derived: net income ÷ weighted average shares · filed 2023-03-08 | -$0.01 derived: net income ÷ weighted average shares · filed 2023-03-08 | -$0.07 derived: net income ÷ weighted average shares · filed 2023-03-08 | -$0.12 10-K · filed 2022-03-04 |
| 2020-09-30 | -$0.08 10-Q · filed 2021-11-04 | -$0.13 derived: net income ÷ weighted average shares · filed 2021-11-04 | -$0.18 10-Q · filed 2021-11-04 | |
| 2020-06-30 | -$0.06 10-Q · filed 2021-08-05 | -$0.11 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | -$0.05 10-Q · filed 2021-05-25 | |||
| 2019-12-31 | -$0.13 10-K · filed 2022-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |